Figure 7. Correlation of transcriptional addiction gene signature with therapeutic drug sensitivity and immune status in TCGA-LIHC set. (A) TIDE scores in different risk groups. (B) Exclusion scores in different risk groups. (C) Cisplatin sensitivity in different risk groups. (D) Sorafenib sensitivity in different risk groups. (E) Correlation between DNA stemness score and risk score. (F) Correlation between RNA stemness score and risk score. (G) Immune cell contents in different risk groups. (H) Immune function scores in different risk groups. *p < 0.05; **p < 0.01; ***p < 0.001.